- Report
- September 2026
- 196 Pages
Global
From €3236EUR$3,545USD£2,773GBP
€3595EUR$3,939USD£3,081GBP
- Report
- June 2026
- 200 Pages
Global
From €2729EUR$2,990USD£2,339GBP
- Report
- September 2026
- 183 Pages
Global
From €3236EUR$3,545USD£2,773GBP
€3595EUR$3,939USD£3,081GBP
- Report
- September 2026
- 194 Pages
Global
From €3236EUR$3,545USD£2,773GBP
€3595EUR$3,939USD£3,081GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Report
- February 2026
- 250 Pages
Global
From €4098EUR$4,490USD£3,512GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2546EUR$2,789USD£2,181GBP
- Report
- November 2025
- 200 Pages
Global
From €7256EUR$7,950USD£6,218GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1369EUR$1,500USD£1,173GBP
- Report
- May 2024
- 137 Pages
Global
From €2737EUR$2,999USD£2,346GBP
€3650EUR$3,999USD£3,128GBP
- Report
- May 2024
- 138 Pages
Global
From €2737EUR$2,999USD£2,346GBP
€3650EUR$3,999USD£3,128GBP
- Report
- May 2023
- 103 Pages
Global
From €3500EUR$4,108USD£3,104GBP

Risedronate is a medication used to treat and prevent osteoporosis, a condition characterized by weak and brittle bones. It belongs to a class of drugs known as bisphosphonates, which work by slowing down the rate of bone breakdown and increasing bone density. Risedronate is also used to treat Paget's disease of bone, a disorder that causes abnormal bone growth and pain. It is available in both oral and intravenous forms.
Risedronate is a widely used drug in the Endocrine and Metabolic Disorders Drugs market. It is used to treat and prevent osteoporosis, a condition that affects millions of people worldwide. It is also used to treat Paget's disease of bone, a rare disorder that causes abnormal bone growth and pain. Risedronate is generally well-tolerated and has few side effects.
Some companies in the Risedronate market include Merck & Co., Inc., Teva Pharmaceuticals, and Mylan N.V. These companies manufacture and distribute the drug in various forms, including tablets, capsules, and injections. Show Less Read more